UK markets closed

SHL Telemedicine Ltd. (0QMX.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
4.1300-1.1200 (-21.33%)
At close: 04:41PM BST
Full screen
Previous close5.2500
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0000 - 0.0000
52-week range
Volume334,250
Avg. volume1,915
Market capN/A
Beta (5Y monthly)0.43
PE ratio (TTM)N/A
EPS (TTM)-0.9720
Earnings date19 Sept 2024 - 23 Sept 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity

    TEL AVIV & ZURICH & NEW YORK, June 20, 2024--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, has clarified today that it is in discussions with Discount Capital Ltd. the investment arm of Israel Discount Bank, regarding a possible investment relating to SHL’s Israeli activity. At this point, the parties have not yet taken any decision nor entered into any binding obligation with regard to th

  • Business Wire

    SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test

    TEL AVIV, Israel & ZURICH & NEW YORK, May 21, 2024--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is proud to announce that it has expanded its offering in Israel to include the groundbreaking ability to perform at-home Biomarker blood tests.

  • Business Wire

    SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch

    TEL AVIV, Israel & ZURICH, & NEW YORK, May 16, 2024--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is thrilled to announce that it recently officially launched it’s SmartHeart® membership program in the US.